Summary
Relapsing Polychondritis (RP) is a systemic disorder characterized by an inflammatory process involving predominantly cartilaginous structures and the cardiovascular system. Lymphadenopathy is a very uncommon finding of RP. We report on a patient affected by RP presenting with lymphadenopathy of Castleman-like type quickly responsive to corticosteroids. The bronchial involvement and the evolution of the inflammatory process in a 3-year follow-up has been documented by computed tomography of the chest.
Similar content being viewed by others
References
Herman JH. Polychondritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of Rheumatology. Philadelphia, Saunders, 1993, 1400–11.
McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 1976; 55: 193–215.
Frizzera G. Systemic Castleman's disease. Am J Surg Pathol 1991; 15: 192.
Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, Katz SI. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978; 299: 1203–7.
Meyer O, Cyna J, Dryll A, Cywiner-Golenzer C, Wassef M, Ryckewaert A. Relapsing polychondritis. Pathogenic role of anti-native collagen type II antibodies. A case report with immunological and pathological studies. J Rheumatol 1981; 8: 820–4.
Svenson KL, Holmdahl R, Klareskog L, Wibell L, Sjoberg O, Klintmalm GB et al. Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol 1984; 13: 329–33.
Riccieri V, Spadaro A, Taccari E, Zoppini A. A case of relapsing polychondritis: pathogenetic considerations. Clin Exp Rheumatol 1988; 6: 95–6.
Alsalameh S, Mollenhauer J, Scheuplein K, Stoss H, Kalden JR, Burkhardt H, et al. Preferential cellular and humoral immune reactivities to native and denaturated collagen types IX and XI in a patient with fatal relapsing polychondritis. J Rheumatol 1993; 20: 1419–24.
Gibson GJ. Relapsing polychondritis. In “Lung disease in rheumatic disorders”. Baillière's Clin Rheum 1993; 7: 179–81.
Mendelson DS, Som PM, Crane R, Cohen BA, Spiera H. Relapsing polychondritis studied by computed tomography. Radiology 1985; 157: 489–90.
Goddard P, Cook P, Laszlo G, Glover SC. Relapsing polychondritis: report of an unusual case and a review of the literature. Br J Radiol 1991; 64: 1064–7.
Miller SB, Donlan CJ, Roth SB. Hodgkin's disease presenting as relapsing polychondritis. Arthritis Rheum 1974; 17: 598–602.
Frizzera G, Moran EM, Rappaport H. Angio-Immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med 1975; 59: 803–18.
Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Thaeo L, Aozasa K, et al. Pathogenetic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360–7.
Frizzera G. Castleman's Disease: more questions than answers. Hum Pathol 1985; 16: 202–5
Isaak BL, Liesegang TJ, Michet CJ Jr. Ocular and systemic findings in relapsing polychondritis. Ophthalmology 1986; 93: 681–9.
Michet CJ, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104: 74–8.
ter Borg E-J, Piers A, Thijn CJP. Increased cartilaginous uptake on bone scintigraphy in a patient with relapsing polychondritis. Eur J Nucl Med 1988; 14: 427–8.
Kao C-H, Wang S-J, Yeh S-H. Radionuclide imaging of relapsing polychondritis. Clin Nucl Med 1992; 17: 397–8.
Author information
Authors and Affiliations
Additional information
Deceased
Rights and permissions
About this article
Cite this article
Manganelli, P., Quaini, F., Olivetti, G. et al. Relapsing polychondritis with Castleman-like lymphadenopathy: a case report. Clin Rheumatol 16, 480–484 (1997). https://doi.org/10.1007/BF02238942
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02238942